Celebrating Moores Cancer Center’s 2025 Top Doctors
|
We’re proud to share that many UC San Diego Health physicians were recognized in the 2025 San Diego Magazine “Physicians of Exceptional Excellence” survey, honoring the region’s finest across 50 specialties. A special congratulations to our Moores Cancer Center physicians who made the list, recognized by their peers for their clinical excellence, compassion, and leadership in cancer care and research. Read more»
|
Diane Simeone, MD, Elected to AACI Board of Directors |
|
|
Moores Cancer Center Director Diane M. Simeone, MD, has been elected to the Board of Directors of the Association of American Cancer Institutes (AACI). In this role, she will collaborate with cancer center leaders across the country to accelerate discovery, expand access to care, and strengthen the collective impact of academic cancer centers nationwide. Read more»
|
How to Be a Successful Clinical Trial Principal Investigator
|
In a recent ASCO Daily News article, Ramez N. Eskander, MD, Rana R. McKay, MD, FASCO, and Joyce Nancarrow Tull, MSN, RN outline core principles for success as oncology clinical trial investigators. From trial selection to patient safety, they provide a practical roadmap for turning research into real-world impact and advancing cancer care through clinical research excellence. Read more»
|
| |
Congratulations to NCI Early Career Scientist Awardee Joshua Demb, PhD
|
We’re proud to share that Joshua Demb, PhD, has been awarded the NCI Division of Cancer Prevention Early Career Scientist Award for his outstanding research in early colorectal cancer detection. This national recognition highlights Dr. Demb’s impactful contributions to cancer prevention and early detection. Congratulations!
|
|
|
Robert Signer, PhD, Awarded Two Major Grants to Advance Stem Cell and Hematologic Malignancy Research |
Congratulations to Robert Signer, PhD, on receiving two significant grants to support his research in stem cell biology and blood cancers — a Discovery Research Grant from the Edward P. Evans Foundation and an R01 from the NIH/NHLBI. These awards will advance Dr. Signer’s investigations into how proteostasis and protein aggregation influence hematopoietic stem cell function, clonal evolution, and disease progression in bone marrow failure syndromes and myeloid malignancies.
|
|
|
LEGENDS OF SCIENCE AND SURFING RECAP |
|
|
On September 12th, the Legends of Science and Surfing Oncology Symposium united trailblazing researchers, clinicians, and cancer warriors for a powerful day of science, innovation, and shared purpose. The energy rolled right into the next day, as surfing legends hit the waves, reminding us all of the strength, courage, and spirit that drives the fight against cancer.
Thanks to everyone who joined us, supported, and made this incredible event possible. Together, we raised vital funds for Moores Cancer Center at UC San Diego Health, propelling groundbreaking research and compassionate care forward. Let’s keep riding this wave of hope and discovery together.
|
|
|
Save the Date: 2025 Moores Cancer Center Annual Scientific Retreat |
The 2025 Moores Cancer Center Annual Scientific Retreat will be held on Thursday, November 6, 2025, from 7:30 a.m. to 5:00 p.m. at Scripps Seaside Forum.
This full-day event brings together faculty, trainees, staff, and research collaborators to exchange ideas and showcase advances across the cancer research continuum — from discovery science to clinical translation. The program will feature scientific presentations, a research poster session, and networking opportunities hosted by the Office of Translational Science.
Join us for a day dedicated to collaboration, innovation, and discovery in cancer research.
RSVP Now» | Submit a poster»
|
|
|
Cervical Cancer Quality Improvement Learning Collaborative Session II
|
Time: Wednesday, October 15th from 12:00 to 1:00 p.m.
Place: Zoom
This series is designed to help practitioners address barriers to cervical cancer elimination. Register here»
|
|
Revvity Solutions for Cancer Research |
Time: October 14th, from 10:30 a.m. to 1:00 p.m.
Place: MCC 2nd floor Research Towers
Revvity will visit Moores Cancer Center to share new tools for cancer research. Stop by to see emerging innovations in action. Learn more»
|
|
|
FEATURED FUNDING OPPORTUNITIES |
View featured limited submission, federal, and non-federal grant and funding opportunities. |
American Cancer Society (ACS) Institutional Research Grant 2026 |
Moores Member Michael Bouvet, MD, Member of the Local Committee of the ACS Institutional Research Grant (ACS-IRG-24-1317140-51-IRG), is pleased to announce the availability of seed money to stimulate cancer research projects of high merit among junior investigators at UC San Diego.
|
Application Deadline: November 10, 2025
Apply Now»
|
Hanna and Mark Gleiberman Head & Neck Cancer Center 2025 Research Pilot Project Grant Opportunity
|
The UC San Diego Health Gleiberman Head and Neck Cancer Center is seeking applications for pilot project grants under the Gleiberman Head and Neck Cancer Center Pilot Project Grant Award Program that will ultimately improve curative therapy as well as the quality of care for head and neck cancer patients and their families. Research proposals may be focused on any aspect of head and neck cancer care or head and neck and/or voice disease etiology, diagnosis, therapy.
|
Application Deadline: November 14, 2025
Apply Now»
|
|
|
| Proteostasis disruption in inherited bone marrow failure syndromes |
Robert Signer, PhD (Hematologic Malignancies) and Helena Yu, MD (Hematologic Malignancies)
|
|
|
|
Cigarette smoking decline among U.S. young adults from 2000 to 2019, in relation to state-level cigarette price and tobacco control expenditure |
Karen Messer, PhD (Cancer Control [CC]), John P. Pierce, PhD (CC), Matthew D. Stone, PhD (CC), Yuyan Shi, PhD (CC), David R. Strong, PhD (CC), Dennis R. Trinidad, PhD, MPH (CC), and Sara B. McMenamin, PhD, MPH (CC)
|
|
|
|
Extrachromosomal DNA-driven oncogene spatial heterogeneity and evolution in glioblastoma |
Vineet Bafna, PhD (Structural and Functional Genomics)
|
|
|
CLINICAL TRIALS OFFICE (CTO) |
|
|
PEAK-1: A Randomized, Double-Blind, Active-Control, Multicenter Phase 3 Trial of Casdatifan and Cabozantinib Versus Placebo and Cabozantinib in Patients With Advanced Clear Cell Renal Cell Carcinoma
PI: Rana McKay, MD
NCT ID: NCT07011719
NRG-CC014: Radiation Therapy for High-Risk Asymptomatic Bone Metastases: A Pragmatic Multicenter Randomized Phase 3 Clinical Trial (PREEMPT)
PI: Dominique Rash, MD
NCT ID: NCT06745024
TRX103-01: Phase I, First in Human, Open Label Study to Evaluate Safety and Tolerability of TRX103 Cells in Subjects With Hematological Malignancies Undergoing HLA-mismatched Related or Unrelated Hematopoietic Stem Cell Transplantation (HSCT)
PI: James Mangan, MD, PhD
NCT ID: NCT06462365
|
|
|
COMMUNITY OUTREACH AND ENGAGEMENT (COE)
|
The COE team continues its mission to reduce the cancer burden in San Diego through education, prevention, and meaningful community partnerships. Last week, the team participated in several impactful initiatives:
|
- Collaborated with teens from across San Diego to record The Science of Podcast, a project highlighting youth perspectives in health communication. Next live recording: November 3, 5 to 7 PM
- Participated in the Latine Pride Festival, sharing cancer prevention resources and connecting with attendees
-
Delivered a Breast Cancer Awareness Month presentation at Lemon Grove Academy, focusing on early detection and self-advocacy.
- In partnership with the UCSD Equity Team, provided A1C and blood pressure checks, along with cancer education, to over 18 individuals at the Mexican Consulate.
- Engaged families at the YMCA’s “Day at the Bay” in conversations about healthy living and cancer risk reduction.
|
|
|
|
